Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.10.0.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Revenue:        
Total revenue $ 521,766 $ 646,061 $ 1,771,313 $ 1,737,790
Costs and expenses:        
Cost of products and services 234,320 328,743 829,155 852,039
Research and development 262,054 239,326 910,862 744,565
Selling and marketing 223,286 301,676 722,696 814,796
General and administrative 735,505 901,588 2,270,953 2,655,054
Total operating costs and expenses 1,455,165 1,771,333 4,733,666 5,066,454
Operating loss (933,399) (1,125,272) (2,962,353) (3,328,664)
Other expense:        
Interest expense (733,209) (1,554,379) (3,015,596) (4,431,950)
Other expense (1,283) (15,595) (7,108)
(Loss) gain on extinguishment of debt (140,765) 90,862 335,132 90,862
Incentive shares/warrants (663,130) (186,802)
Change in fair value of derivative liabilities 245,213 (26,014)
Total other (expense) income (875,257) (1,218,304) (3,359,189) (4,561,012)
Net loss (1,808,656) (2,343,576) (6,321,542) (7,889,676)
Deemed dividend on down round feature (213,012)
Deemed dividend on beneficial conversion feature (1,146,280) (11,678,571)
Preferred stock dividends (277,439) (373,318)
Net loss attributable to common stockholders $ (3,232,375) $ (2,343,576) $ (18,586,443) $ (7,889,676)
Basic and diluted net loss per share attributable to common stockholders $ (2.01) $ (2.07) $ (12.67) $ (7.28)
Weighted average common stock shares outstanding used in the basic and diluted net loss per share calculation 1,606,575 1,133,791 1,466,424 1,084,370
Products, Services, Other [Member]        
Revenue:        
Total revenue $ 461,017 $ 603,726 $ 1,664,679 $ 1,610,124
Grant Revenue [Member]        
Revenue:        
Total revenue $ 60,749 $ 42,335 $ 106,634 $ 127,666